Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Changes in Stockholders Equity

v3.22.2.2
Unaudited Condensed Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Common Shares Issuable [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2020 $ 3 $ 95   $ 583,000 $ (482,760) $ 96,661 $ 196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492          
Stock-based compensation expense       12,449     12,449
Issuance of common stock related to equity plans   $ 3   (3)      
Issuance of common stock related to equity plans (in shares)   2,912,652          
Issuance of common stock under ESPP       137     137
Issuance of common stock under ESPP (in shares)   59,107          
Issuance of common stock for at-the-market offering, net   $ 1   2,747     2,748
Issuance of common stock for at-the-market offering, net (in shares)   786,300          
Preferred A dividends declared and paid       (6,023)     (6,023)
Partner company's at-the-market offering, net       101,958     101,958
Issuance of common stock under partner company's ESPP       309     309
Partner company's dividends declared and paid       (562)     (562)
Common shares issued for dividend on partner company's convertible preferred shares       263     263
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   78,671          
Common shares issuable for dividend on partner company's convertible preferred shares     $ 365       365
Issuance (reversal) of partner company's common shares for research and development expenses       136     136
Partner company's exercise of options for cash       7     7
Non-controlling interest in partner companies       (86,329)   86,329  
Net loss attributable to non-controlling interest           (63,180) (63,180)
Net loss attributable to common stockholders         (33,138)   (33,138)
Balance at Sep. 30, 2021 $ 3 $ 99 $ 365 608,089 (515,898) 119,810 212,468
Balance (in shares) at Sep. 30, 2021 3,427,138 98,714,222 365,000        
Balance at Jun. 30, 2021 $ 3 $ 97 $ 263 603,035 (495,117) 140,020 248,301
Balance (in shares) at Jun. 30, 2021 3,427,138 97,495,244          
Stock-based compensation expense       4,326     4,326
Issuance of common stock related to equity plans   $ 1   (1)      
Issuance of common stock related to equity plans (in shares)   354,007          
Issuance of common stock for at-the-market offering, net   $ (1)   (2,747)     (2,748)
Issuance of common stock for at-the-market offering, net (in shares)   786,300          
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's at-the-market offering, net       4,626     4,626
Issuance of common stock under partner company's ESPP       (151)     (151)
Partner company's dividends declared and paid       (187)     (187)
Common shares issued for dividend on partner company's convertible preferred shares       263      
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   78,671 (263,000)        
Common shares issuable for dividend on partner company's convertible preferred shares     $ 365       365
Non-controlling interest in partner companies       (4,870)   4,870  
Net loss attributable to non-controlling interest           (25,080) (25,080)
Net loss attributable to common stockholders         (20,781)   (20,781)
Balance at Sep. 30, 2021 $ 3 $ 99 $ 365 608,089 (515,898) 119,810 212,468
Balance (in shares) at Sep. 30, 2021 3,427,138 98,714,222 365,000        
Balance at Dec. 31, 2021 $ 3 $ 101   656,033 (547,463) 117,203 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 101,435,505          
Stock-based compensation expense       17,481     17,481
Issuance of common stock related to equity plans   $ 3   (3)      
Issuance of common stock related to equity plans (in shares)   2,953,703          
Issuance of common stock under ESPP       99     99
Issuance of common stock under ESPP (in shares)   135,464          
Issuance of common stock for at-the-market offering, net   $ 4   5,746     5,750
Issuance of common stock for at-the-market offering, net (in shares)   3,734,681          
Preferred A dividends declared and paid       (6,024)     (6,024)
Partner company's at-the-market offering, net       16,193     16,193
Issuance of common stock under partner company's ESPP       206     206
Partner company's dividends declared and paid       (563)     (563)
Partner company's net settlement of shares withheld for taxes       (1,698)     (1,698)
Partner company's warrants issued in conjunction with debt       384     384
Issuance (reversal) of partner company's common shares for research and development expenses       (27)     (27)
Partner company's exercise of options for cash       142     142
Non-controlling interest in partner companies       (19,319)   19,319  
Net loss attributable to non-controlling interest           (96,841) (96,841)
Net loss attributable to common stockholders         (59,627)   (59,627)
Balance at Sep. 30, 2022 $ 3 $ 108   668,650 (607,090) 39,681 101,352
Balance (in shares) at Sep. 30, 2022 3,427,138 108,259,353          
Balance at Jun. 30, 2022 $ 3 $ 108   661,691 (584,579) 70,479 147,702
Balance (in shares) at Jun. 30, 2022 3,427,138 107,717,647          
Stock-based compensation expense       6,837     6,837
Issuance of common stock related to equity plans (in shares)   307,328          
Issuance of common stock for at-the-market offering, net       223     223
Issuance of common stock for at-the-market offering, net (in shares)   234,378          
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's at-the-market offering, net       1,717     1,717
Issuance of common stock under partner company's ESPP       90     90
Partner company's dividends declared and paid       (188)     (188)
Issuance (reversal) of partner company's common shares for research and development expenses       8     8
Partner company's exercise of options for cash       31     31
Non-controlling interest in partner companies       249   (249)  
Net loss attributable to non-controlling interest           (30,549) (30,549)
Net loss attributable to common stockholders         (22,511)   (22,511)
Balance at Sep. 30, 2022 $ 3 $ 108   $ 668,650 $ (607,090) $ 39,681 $ 101,352
Balance (in shares) at Sep. 30, 2022 3,427,138 108,259,353